(Updated - December 19, 2025 7:50 AM EST)

Guggenheim analyst Debjit Chattopadhyay raised the price target on Maze Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE